Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

755 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
Visseren T, Erler NS, Polak WG, Adam R, Karam V, Vondran FWR, Ericzon BG, Thorburn D, IJzermans JNM, Paul A, van der Heide F, Taimr P, Nemec P, Pirenne J, Romagnoli R, Metselaar HJ, Darwish Murad S; European Liver and Intestine Transplantation Association (ELITA). Visseren T, et al. Among authors: ijzermans jnm. Transpl Int. 2021 Aug;34(8):1455-1467. doi: 10.1111/tri.13925. Epub 2021 Jun 28. Transpl Int. 2021. PMID: 34028110 Free PMC article.
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference.
Mehta N, Bhangui P, Yao FY, Mazzaferro V, Toso C, Akamatsu N, Durand F, Ijzermans J, Polak W, Zheng S, Roberts JP, Sapisochin G, Hibi T, Kwan NM, Ghobrial M, Soin A. Mehta N, et al. Among authors: ijzermans j. Transplantation. 2020 Jun;104(6):1136-1142. doi: 10.1097/TP.0000000000003174. Transplantation. 2020. PMID: 32217938 Free article. Review.
A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ, IJzermans JNM. van Vugt JLA, et al. Among authors: ijzermans jnm. J Hepatol. 2018 Apr;68(4):707-714. doi: 10.1016/j.jhep.2017.11.030. Epub 2017 Dec 6. J Hepatol. 2018. PMID: 29221886
Development and Validation of a Model to Predict Regression of Large Size Hepatocellular Adenoma.
Klompenhouwer AJ, Alblas M, van Rosmalen BV, Haring MPD, Venema E, Doukas M, Thomeer MGJ, Takkenberg RB, Verheij J, de Meijer VE, van Gulik TM, Lingsma HF, de Man RA, Ijzermans JNM. Klompenhouwer AJ, et al. Among authors: ijzermans jnm. Am J Gastroenterol. 2019 Aug;114(8):1292-1298. doi: 10.14309/ajg.0000000000000182. Am J Gastroenterol. 2019. PMID: 30920416
Growth of hepatocellular adenoma during pregnancy: A prospective study.
Gaspersz MP, Klompenhouwer AJ, Broker MEE, Thomeer MGJ, van Aalten SM, Steegers E, Terkivatan T, de Koning H, de Man RA, Ijzermans JNM. Gaspersz MP, et al. J Hepatol. 2020 Jan;72(1):119-124. doi: 10.1016/j.jhep.2019.09.011. Epub 2019 Sep 21. J Hepatol. 2020. PMID: 31550458
755 results